Horizon partners with big pharma company on CRISPR
29-08-2018
EPO grants second CRISPR patent to ERS Genomics
07-03-2018
CRISPR in Europe: the patent landscape for 2018
30-11-2017
Horizon Discovery expands CRISPR licence
17-01-2017
UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Horizon Discovery, genetics, gene editing, ERS Genomics, licence, CRISPR, technology
